Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12:16:1593959.
doi: 10.3389/fendo.2025.1593959. eCollection 2025.

Management of patients with acromegaly in clinical practice in the gulf countries: a Delphi consensus survey

Mussa H Almalki  1   2 , Tarik Elhadd  3 , Khaled M AlDahmani  4   5   6 , Aishah Ekhzaimy  7 , Abdullah Alqanaei  8 , Hasan Frookh  9 , Arwa Alyamani  10 , Osamah Hakami  10 , Zeinab Dabbous  3 , Zaina Rohani  3 , Wael Almistehi  1 , Hazem Aljumah  11 , Abdulla Alfutaisi  12 , Alaaeldin Bashier  13 , Moeber Mahzari  14   15   16
Affiliations

Management of patients with acromegaly in clinical practice in the gulf countries: a Delphi consensus survey

Mussa H Almalki et al. Front Endocrinol (Lausanne). .

Abstract

Background: Acromegaly management practices in the Gulf region lack standardized guidelines, leading to variability in care. This study aimed to establish evidence-based regional consensus recommendations to address clinical challenges and align management with local healthcare resources.

Methods: A three-round Delphi consensus survey was conducted among 15 endocrinology experts from six Gulf countries. Forty-six statements across six domains-primary treatment, pre-surgery treatment with somatostatin analogs (SSAs), second-line therapy, radiotherapy, post-surgery follow-up, and long-term management-were evaluated. Consensus was predefined as ≥66.8% agreement.

Results: Strong consensus was achieved on surgical resection as first-line therapy for eligible patients (100% agreement), with referrals to multidisciplinary centers emphasized (93.8%). Preoperative SSAs were endorsed to reduce surgical/anesthesia risks in high-risk patients (93.8%). For second-line management, watchful waiting for asymptomatic patients with mildly elevated insulin-like growth factor-1 (IGF-1) (93.8%) and combination therapy (where feasible) were supported. Radiotherapy received unanimous agreement for specific cases. Structured post-surgical follow-up protocols, including biochemical testing timelines and remission criteria, were established. Long-term monitoring emphasized individualized risk assessment.

Discussion: These guidelines provide a regionally tailored framework for acromegaly management, prioritizing surgery as the cornerstone of treatment while integrating adjuvant therapies and follow-up strategies aligned with Gulf healthcare infrastructures. The consensus reflects pragmatic adaptations to resource availability, such as endorsing watchful waiting in specific contexts. While acknowledging limitations such as potential expert bias, these consensus guidelines provide a framework for standardizing acromegaly care across the Gulf countries, with emphasis on surgical intervention as the cornerstone of treatment while recognizing the importance of adjunctive therapies.

Keywords: acromegaly; delphi consensus; gulf region consensus; radiotherapy; surgery; survey; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Evaluated and accepted items in each round and in the final evaluation.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Melmed S. Medical progress: acromegaly. N Engl J Med. (2006) 355:2558–73. doi: 10.1056/NEJMra062453 - DOI - PubMed
    1. Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, et al. Acromegaly. Nat Rev Dis Primers. (2019) 5:20. doi: 10.1038/s41572-019-0129-5 - DOI - PubMed
    1. Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, et al. A pituitary society update to acromegaly management guidelines. Pituitary. (2021) 24:1–13. doi: 10.1007/s11102-020-01091-7 - DOI - PMC - PubMed
    1. Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. (2020) 21:667–78. doi: 10.1007/s11154-020-09588-z - DOI - PMC - PubMed
    1. Bollerslev J, Heck A, Olarescu NC. Management of endocrine disease: individualised management of acromegaly. Eur J Endocrinol. (2019) 181:R57–71. doi: 10.1530/EJE-19-0124 - DOI - PubMed

LinkOut - more resources